This dataset forms part of the OPTIMising therapies, discovering therapeutic targets and AI-assisted clinical management for patients Living with complex multimorbidity (OPTIMAL) NIHR funded programme.

The dataset includes >40,000 adult patients with multimorbidity who were acutely admitted to hospital and had an inpatient stay.  Longitudinal data includes serial physiology readings, frailty scores, blood results, medications, comorbidities, drug allergies, treatments, procedures and mortality outcomes up to a year post discharge.

Geography: The West Midlands (WM) has a population of 6 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & > 120 ITU bed capacity. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”.

Data set availability:  Data access is available via the PIONEER Hub for projects which will benefit the public or patients.  This can be by developing a new understanding of disease, by providing insights into how to improve care, or by developing new models, tools, treatments, or care processes.  Data access can be provided to NHS, academic, commercial, policy and third sector organisations.  Applications from SMEs are welcome.  There is a single data access process, with public oversight provided by our public review committee, the Data Trust Committee.  Contact [email protected] or visit www.pioneerdatahub.co.uk for more details.

All data uses should name both PIONEER and the NIHR Optimal programme in data outputs.  This will be specified in the Data Licensing Agreement.

Available supplementary data: Matched controls; ambulance and community data. Unstructured data (images).  We can provide the dataset in OMOP and other common data models and can build synthetic data to meet bespoke requirements.

Available supplementary support: Analytics, model build, validation & refinement; A.I. support.  Data partner support for ETL (extract, transform & load) processes.  Bespoke and “off the shelf” Trusted Research Environment (TRE) build and run.  Consultancy with clinical, patient & end-user and purchaser access/ support.  Support for regulatory requirements.  Cohort discovery. Data-driven trials and “fast screen” services to assess population size.

Further information including technical details, coverage, format and standards, provenance and related resources can be found on the link below: https://web.www.healthdatagateway.org/dataset/5764caa8-c7ca-41b2-89d5-f38f7d977aa7